Top-News
Rohstoffe Kanada

Mind Medicine (MindMed) News

Aktie
WKN:  A3DR6E ISIN:  CA60255C8850 US-Symbol:  MNMD
7,89 €
-0,075 €
-0,94%
15:52:04 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
39,72 Mio.
Marktkapitalisierung *
316,16 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 30.08.2023

Mind Medicine (MindMed) News

11.11.22 - PR Newswire
MindMed to Participate in the Jefferies London Healthcare Conference
MindMed to Participate in the Jefferies London Healthcare Conference PR Newswire
10.11.22 - PR Newswire
MindMed Reports Third Quarter 2022 Financial Results and Business Highlights
MindMed Reports Third Quarter 2022 Financial Results and Business Highlights PR Newswire
03.11.22 - PR Newswire
MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update
MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update PR Newswire
05.10.22 - PR Newswire
MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference
MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference PR Newswire
04.10.22 - PR Newswire
MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA
MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA PR Newswire
28.09.22 - PR Newswire
MindMed Board is Trippin': Significant Investor Calls for Termination of Highly Dilutive Equity Offering and Pledges to Hold Board and Management Accountable through Activist Campaign
MindMed Board is Trippin': Significant Investor Calls for Termination of Highly Dilutive Equity Offering and Pledges to Hold Board and Management Accountable through Activist ...
28.09.22 - PR Newswire
Thinking about buying stock in Mind Medicine, Credit Suisse, Peabody Energy, Xpeng, or Powerbridge Technologies?
Thinking about buying stock in Mind Medicine, Credit Suisse, Peabody Energy, Xpeng, or Powerbridge Technologies? PR Newswire
27.09.22 - PR Newswire
MindMed Announces Pricing of Public Offering of Common Shares and Warrants
MindMed Announces Pricing of Public Offering of Common Shares and Warrants PR Newswire
27.09.22 - PR Newswire
MindMed Announces Proposed Public Offering of Common Shares
MindMed Announces Proposed Public Offering of Common Shares PR Newswire
20.09.22 - PR Newswire
MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances
MindMed Collaborators Dose First Patient in Phase 1 Investigator-​Initiated Trial of MDMA-Like Substances PR Newswire
14.09.22 - PR Newswire
MindMed Announces Compliance with Nasdaq Listing Requirements
MindMed Announces Compliance with Nasdaq Listing Requirements PR Newswire
08.09.22 - PR Newswire
MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal
MindMed Announces Positive Results from Collaborators' Placebo-​Controlled Investigator-​Initiated Trial Published in Peer-​Reviewed Journal PR Newswire
07.09.22 - PR Newswire
MindMed to Participate in H.C. Wainwright Global Investment Conference
MindMed to Participate in H.C. Wainwright Global Investment Conference PR Newswire
26.08.22 - PR Newswire
MindMed Completes 1-for-15 Reverse Share Split
MindMed Completes 1-for-15 Reverse Share Split PR Newswire
25.08.22 - PR Newswire
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder PR Newswire
22.08.22 - PR Newswire
Thinking about buying stock in Mind Medicine, Endo International, Tilray, BioNano Genomics, or Nikola Corp?
Thinking about buying stock in Mind Medicine, Endo International, Tilray, BioNano Genomics, or Nikola Corp? PR Newswire
19.08.22 - PR Newswire
Thinking about buying stock in Axsome Therapeutics, Foot Locker, Mind Medicine, Digital Media Solutions, or Provention Bio?
Thinking about buying stock in Axsome Therapeutics, Foot Locker, Mind Medicine, Digital Media Solutions, or Provention Bio? PR Newswire
18.08.22 - PR Newswire
Thinking about buying stock in Plus Therapeutics, Mind Medicine, AMC Entertainment, Rigel Pharmaceuticals, or Greenbox POS?
Thinking about buying stock in Plus Therapeutics, Mind Medicine, AMC Entertainment, Rigel Pharmaceuticals, or Greenbox POS? PR Newswire
12.08.22 - PR Newswire
MindMed Strengthens Board with Appointment of Two New Independent Directors
MindMed Strengthens Board with Appointment of Two New Independent Directors PR Newswire
11.08.22 - PR Newswire
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights PR Newswire

Newssuche

Videos

newspaper
08:55 Uhr +11,95%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »